Raymond James Financial Services Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $5.15M | Sell |
23,066
-1,649
| -7% | -$362K | 0.01% | 1204 |
|
|
2024
Q2 | $5.03M | Sell |
24,715
-15,354
| -38% | -$3.12M | 0.01% | 1164 |
|
|
2024
Q1 | $8.75M | Buy |
40,069
+13,024
| +48% | +$2.87M | 0.01% | 869 |
|
|
2023
Q4 | $6.15M | Buy |
27,045
+1,691
| +7% | +$355K | 0.01% | 972 |
|
|
2023
Q3 | $5.1M | Sell |
25,354
-2,718
| -10% | -$573K | 0.01% | 998 |
|
|
2023
Q2 | $5.82M | Sell |
28,072
-1,838
| -6% | -$357K | 0.01% | 936 |
|
|
2023
Q1 | $5.9M | Buy |
29,910
+2,456
| +9% | +$505K | 0.01% | 917 |
|
|
2022
Q4 | $5.55M | Sell |
27,454
-3,550
| -11% | -$694K | 0.01% | 908 |
|
|
2022
Q3 | $5.46M | Buy |
31,004
+4,834
| +18% | +$990K | 0.01% | 877 |
|
|
2022
Q2 | $5.27M | Buy |
26,170
+832
| +3% | +$177K | 0.01% | 899 |
|
|
2022
Q1 | $5.74M | Buy |
25,338
+761
| +3% | +$179K | 0.01% | 931 |
|
|
2021
Q4 | $6.63M | Buy |
24,577
+1,803
| +8% | +$446K | 0.01% | 870 |
|
|
2021
Q3 | $5.51M | Buy |
22,774
+1,377
| +6% | +$347K | 0.01% | 922 |
|
|
2021
Q2 | $5.07M | Sell |
21,397
-1,953
| -8% | -$445K | 0.01% | 968 |
|
|
2021
Q1 | $5.12M | Sell |
23,350
-2,862
| -11% | -$574K | 0.01% | 892 |
|
|
2020
Q4 | $4.58M | Buy |
26,212
+1,447
| +6% | +$250K | 0.01% | 866 |
|
|
2020
Q3 | $4.01M | Sell |
24,765
-5,338
| -18% | -$846K | 0.01% | 852 |
|
|
2020
Q2 | $4.3M | Buy |
30,103
+3,585
| +14% | +$496K | 0.01% | 770 |
|
|
2020
Q1 | $2.88M | Sell |
26,518
-21,297
| -45% | -$3.07M | 0.01% | 732 |
|
|
2019
Q4 | $6.95M | Buy |
47,815
+26,387
| +123% | +$3.81M | 0.02% | 621 |
|
|
2019
Q3 | $3.09M | Buy |
21,428
+347
| +2% | +$50.6K | 0.01% | 885 |
|
|
2019
Q2 | $3.13M | Sell |
21,081
-93
| -0.4% | -$13K | 0.01% | 873 |
|
|
2019
Q1 | $2.78M | Buy |
21,174
+1,433
| +7% | +$177K | 0.01% | 907 |
|
|
2018
Q4 | $2.14M | Sell |
19,741
-2,870
| -13% | -$384K | 0.01% | 866 |
|
|
2018
Q3 | $3.37M | Buy |
22,611
+1,409
| +7% | +$214K | 0.02% | 806 |
|
|
2018
Q2 | $3.27M | Sell |
21,202
-5,987
| -22% | -$904K | 0.02% | 782 |
|
|
2018
Q1 | $3.78M | Buy |
27,189
+10,375
| +62% | +$1.52M | 0.02% | 665 |
|
|
2017
Q4 | $2.3M | Buy |
16,814
+1,840
| +12% | +$243K | 0.01% | 845 |
|
|
2017
Q3 | $1.94M | Sell |
14,974
-436
| -3% | -$58.2K | 0.01% | 931 |
|
|
2017
Q2 | $2.04M | Buy |
15,410
+3,886
| +34% | +$476K | 0.01% | 878 |
|
|
2017
Q1 | $1.42M | Buy |
11,524
+232
| +2% | +$27.5K | 0.01% | 987 |
|
|
2016
Q4 | $1.25M | Sell |
11,292
-516
| -4% | -$57.3K | 0.01% | 996 |
|
|
2016
Q3 | $1.4M | Sell |
11,808
-171
| -1% | -$20.1K | 0.01% | 914 |
|
|
2016
Q2 | $1.34M | Sell |
11,979
-3,750
| -24% | -$404K | 0.01% | 902 |
|
|
2016
Q1 | $1.58M | Sell |
15,729
-10,964
| -41% | -$1.05M | 0.02% | 724 |
|
|
2015
Q4 | $2.83M | Buy |
26,693
+431
| +2% | +$44.5K | 0.03% | 513 |
|
|
2015
Q3 | $2.45M | Buy |
+26,262
| New | +$2.72M | 0.04% | 457 |
|
Other funds holding LH
Raymond James Financial Services Advisors's LH Position: Q3 2024 in Review
Raymond James Financial Services Advisors reduced its Labcorp (LH) stake by 6.7% in Q3 2024, selling an estimated $362K and leaving 23,066 shares worth $5.15M. The position accounts for 0.01% of the portfolio, ranked #1204.
Raymond James Financial Services Advisors first reported a position in LH in Q3 2015 and has held it in 37 quarters since. The position peaked at $8.75M in Q1 2024. 920 funds tracked by Wall St. Rank hold LH as of Q3 2024.
- Raymond James Financial Services Advisors held 23,066 shares of Labcorp worth $5.15M as of Q3 2024.
- Raymond James Financial Services Advisors sold 1,649 Labcorp shares in Q3 2024, an estimated $362K.
- Labcorp made up 0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #1204 holding.
- Raymond James Financial Services Advisors first reported a position in Labcorp in Q3 2015 and has held it in 37 quarters since.
- Raymond James Financial Services Advisors's Labcorp position peaked at $8.75M in Q1 2024.
- 920 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.
Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.